96 related articles for article (PubMed ID: 26610675)
1. The Biochemical and Pathological Correlates of Successful Semen Cryopreservation From Patients With Testicular Cancer: A Single Tertiary Center Experience.
Pong YH; Kao MH; Lu YC; Lee IC; Hsieh JT; Tsai VF; Chang HC
Urology; 2016 Feb; 88():76-80. PubMed ID: 26610675
[TBL] [Abstract][Full Text] [Related]
2. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network.
Rives N; Perdrix A; Hennebicq S; Saïas-Magnan J; Melin MC; Berthaut I; Barthélémy C; Daudin M; Szerman E; Bresson JL; Brugnon F; Bujan L
J Androl; 2012; 33(6):1394-401. PubMed ID: 22837112
[TBL] [Abstract][Full Text] [Related]
3. Gonadal dysfunction in male cancer patients before cytotoxic treatment.
van Casteren NJ; Boellaard WP; Romijn JC; Dohle GR
Int J Androl; 2010 Feb; 33(1):73-9. PubMed ID: 19538481
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the quality of cryopreserved semen from male cancer patients].
Sheng HQ; Zhang XZ; Hong Y
Zhonghua Nan Ke Xue; 2015 Jan; 21(1):44-7. PubMed ID: 25707139
[TBL] [Abstract][Full Text] [Related]
5. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
6. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
[TBL] [Abstract][Full Text] [Related]
7. Sperm cryopreservation in patients with testicular cancer.
Hallak J; Kolettis PN; Sekhon VS; Thomas AJ; Agarwal A
Urology; 1999 Nov; 54(5):894-9. PubMed ID: 10565754
[TBL] [Abstract][Full Text] [Related]
8. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
9. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
[TBL] [Abstract][Full Text] [Related]
10. Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones.
de Bruin D; de Jong IJ; Arts EG; Nuver J; Dullaart RP; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
Fertil Steril; 2009 Jun; 91(6):2481-6. PubMed ID: 18440530
[TBL] [Abstract][Full Text] [Related]
11. Sperm concentration, hyaluronic acid-binding capacity, aneuploidy and persistent histones in testicular cancer.
Molnar Z; Mokanszki A; Kassai Bazsane Z; Bhattoa HP; Benyo M; Olah E; Jakab A
Hum Reprod; 2014 Sep; 29(9):1866-74. PubMed ID: 25047166
[TBL] [Abstract][Full Text] [Related]
12. Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
Hamano I; Hatakeyama S; Nakamura R; Fukuhara R; Noro D; Tanaka T; Yoneyama T; Yamamoto H; Yoneyama T; Hashimoto Y; Koie T; Yokoyama Y; Ohyama C
Int J Urol; 2018 Sep; 25(9):817-824. PubMed ID: 29963714
[TBL] [Abstract][Full Text] [Related]
13. Predictors of spermatogenesis in orchiectomy specimens.
Choy JT; Wiser HJ; Bell SW; Cashy J; Brannigan RE; Köhler TS
Urology; 2013 Feb; 81(2):288-92. PubMed ID: 23374785
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy.
Sposito C; Camargo M; Tibaldi DS; Barradas V; Cedenho AP; Nichi M; Bertolla RP; Spaine DM
Int Braz J Urol; 2017; 43(4):644-651. PubMed ID: 28266817
[TBL] [Abstract][Full Text] [Related]
15. Reduced semen quality in patients with testicular cancer seminoma is associated with alterations in the expression of sperm proteins.
Dias TR; Agarwal A; Pushparaj PN; Ahmad G; Sharma R
Asian J Androl; 2020; 22(1):88-93. PubMed ID: 31006710
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
Keskin S; Ekenel M; Başaran M; Bavbek S
Am J Clin Oncol; 2012 Aug; 35(4):369-72. PubMed ID: 22814307
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipid peroxidation on cryopreserved semen quality in patients with testicular or nontesticular cancer.
Wang Y; Sharma RK; Agarwal A
Urology; 1997 Sep; 50(3):414-7. PubMed ID: 9301707
[TBL] [Abstract][Full Text] [Related]
18. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies.
Said TM; Tellez S; Evenson DP; Del Valle AP
Andrologia; 2009 Dec; 41(6):377-82. PubMed ID: 19891636
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment semen parameters in men with cancer.
Williams DH; Karpman E; Sander JC; Spiess PE; Pisters LL; Lipshultz LI
J Urol; 2009 Feb; 181(2):736-40. PubMed ID: 19091343
[TBL] [Abstract][Full Text] [Related]
20. Individual and seminal characteristics of patients with testicular germ cell tumors.
Fraietta R; Spaine DM; Bertolla RP; Ortiz V; Cedenho AP
Fertil Steril; 2010 Nov; 94(6):2107-12. PubMed ID: 20117767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
